Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tibor Bedekovics

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Oncotarget|September 10, 2019
Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogeneTibor Bedekovics, Sajjad Hussain, Paul J Galardy
British Journal of Haematology|March 29, 2016
Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizonsPaul J Galardy, Tibor Bedekovics, Michelle L Hermiston
FEMS Yeast Research|August 31, 2007
Partial conservation of functions between eukaryotic frataxin and the Escherichia coli frataxin homolog CyaYTibor Bedekovics, Gabriella B Gajdos, Gyula Kispal, et al.
The Journal of Biological Chemistry|September 20, 2011
Leucine biosynthesis regulates cytoplasmic iron-sulfur enzyme biogenesis in an Atm1p-independent mannerTibor Bedekovics, Hongqiao Li, Gabriella B Gajdos, et al.
British Journal of Haematology|February 21, 2019
Lymphoma diagnostics: getting more from lessPaul J Galardy, Tibor Bedekovics, Elizabeth Macintyre, et al.
Blood|December 25, 2015
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphomaTibor Bedekovics, Sajjad Hussain, Andrew L Feldman, et al.
Oncotarget|October 30, 2015
UCHL1 is a biomarker of aggressive multiple myeloma required for disease progressionSajjad Hussain, Tibor Bedekovics, Marta Chesi, et al.
The Journal of Investigative Dermatology|January 19, 2006
Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey diseaseRichard Kellermayer, Réka Szigeti, Kim M Keeling, et al.
Cancer Research|December 23, 2020
<i>USP24</i> Is a Cancer-Associated Ubiquitin Hydrolase, Novel Tumor Suppressor, and Chromosome Instability Gene Deleted in NeuroblastomaTibor Bedekovics, Sajjad Hussain, Ying Zhang, et al.
The Journal of Biological Chemistry|October 5, 2010
Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assemblyOleksandr Gakh, Tibor Bedekovics, Samantha F Duncan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oncotarget|September 10, 2019
Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogeneTibor Bedekovics, Sajjad Hussain, Paul J Galardy
British Journal of Haematology|March 29, 2016
Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizonsPaul J Galardy, Tibor Bedekovics, Michelle L Hermiston
FEMS Yeast Research|August 31, 2007
Partial conservation of functions between eukaryotic frataxin and the Escherichia coli frataxin homolog CyaYTibor Bedekovics, Gabriella B Gajdos, Gyula Kispal, et al.
The Journal of Biological Chemistry|September 20, 2011
Leucine biosynthesis regulates cytoplasmic iron-sulfur enzyme biogenesis in an Atm1p-independent mannerTibor Bedekovics, Hongqiao Li, Gabriella B Gajdos, et al.
British Journal of Haematology|February 21, 2019
Lymphoma diagnostics: getting more from lessPaul J Galardy, Tibor Bedekovics, Elizabeth Macintyre, et al.
Blood|December 25, 2015
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphomaTibor Bedekovics, Sajjad Hussain, Andrew L Feldman, et al.
Oncotarget|October 30, 2015
UCHL1 is a biomarker of aggressive multiple myeloma required for disease progressionSajjad Hussain, Tibor Bedekovics, Marta Chesi, et al.
The Journal of Investigative Dermatology|January 19, 2006
Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey diseaseRichard Kellermayer, Réka Szigeti, Kim M Keeling, et al.
Cancer Research|December 23, 2020
<i>USP24</i> Is a Cancer-Associated Ubiquitin Hydrolase, Novel Tumor Suppressor, and Chromosome Instability Gene Deleted in NeuroblastomaTibor Bedekovics, Sajjad Hussain, Ying Zhang, et al.
The Journal of Biological Chemistry|October 5, 2010
Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assemblyOleksandr Gakh, Tibor Bedekovics, Samantha F Duncan, et al.
Pageof 2